A platform-based regulatory management of recurrent vaccine composition updates using the Post‑Approval Change Management Protocol (PACMP)—The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan
A platform-based regulatory management of recurrent vaccine composition updates using the Post‑Approval Change Management Protocol (PACMP)—The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan. // Cell Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2590136226001087?dgcid=rss_sd_all
A platform-based regulatory management of recurrent vaccine composition updates using the Post‑Approval Change Management Protocol (PACMP)—The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan. Cell Reports. https://www.sciencedirect.com/science/article/pii/S2590136226001087?dgcid=rss_sd_all
“A platform-based regulatory management of recurrent vaccine composition updates using the Post‑Approval Change Management Protocol (PACMP)—The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan.” Cell Reports.
@article{article11452,
title = {A platform-based regulatory management of recurrent vaccine composition updates using the Post‑Approval Change Management Protocol (PACMP)—The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan},
journal = {Cell Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2590136226001087?dgcid=rss_sd_all}
}